The global NICU genetic testing market is forecast to grow from USD 1.74 billion in 2026 to USD 4.80 billion by 2036, at a 10.67% CAGR. Growth is driven by rising neonatal genetic disorders, rapid ...
Weekly OverviewThis week, there were no studies that single-handedly overturned standard clinical practice. However, there are several studies that could improve clinical 'risk stratification'.Most im ...
14d
Helix Launches Whole Exome+® Sequencing for Patients with Rare and Unexplained Genetic Conditions
Helix, the leading enterprise genomics platform, today announced the availability of Whole Exome+® Sequencing (WES+), a comprehensive diagnostic sequencing test now available to ordering providers ...
Follow-up testing after atypical cell-free DNA (cfDNA) screening, sometimes used in FNAIT assessment, may identify genetic ...
Whole Exome+ Sequencing integrates exome, mitochondrial, and digital karyotype analysis, aiming to reduce standalone CMA ...
주거환경과 디지털기기의 과도한 사용 등으로 어른들은 물론 청소년, 아동에 이르기까지 수면장애를 호소하는 환자들이 늘고 있다. 이들은 대부분 특별한 기저 질환이 없다. 그러나 희귀질환에는 수면장애가 특징적으로 동반되는 질환들이 ...
Noninvasive prenatal testing (NIPT), which utilizes high-throughput sequencing technology to analyze cell-free DNA fragments from maternal peripheral plasma, has been widely adopted in clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results